Novel use of low-dose radiotherapy to modulate the tumor microenvironment of liver metastases
K He, HB Barsoumian, G Bertolet, V Verma… - Frontiers in …, 2021 - frontiersin.org
Despite multiple therapeutic approaches, the presence of liver metastases carries a guarded
prognosis, urgently necessitating further clinical and scientific research to develop curative …
prognosis, urgently necessitating further clinical and scientific research to develop curative …
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
RR Patel, K He, HB Barsoumian, JY Chang… - Radiotherapy and …, 2021 - Elsevier
Aim To report early findings from a phase II trial of high-dose radiotherapy (HD-RT) with or
without low-dose RT (LD-RT) for metastatic cancer. Methods Eligible patients had metastatic …
without low-dose RT (LD-RT) for metastatic cancer. Methods Eligible patients had metastatic …
Group phenotypic composition in cancer
Although individual cancer cells are generally considered the Darwinian units of selection in
malignant populations, they frequently act as members of groups where fitness of the group …
malignant populations, they frequently act as members of groups where fitness of the group …
Immunotherapy combined with high-and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma
D Sezen, RR Patel, C Tang, M Onstad, P Nagarajan… - Gynecologic …, 2021 - Elsevier
A 73-year-old woman with metastatic vaginal mucosal melanoma that had progressed on
ipilimumab and nivolumab experienced clinical and radiographic complete response to dual …
ipilimumab and nivolumab experienced clinical and radiographic complete response to dual …
[HTML][HTML] Thoracic stereotactic body radiation therapy plus first-line tyrosine kinase inhibitors for patients with epidermal growth factor receptor-mutant polymetastatic …
X Wang, Z Lu, Z Zeng, J Cai, P Xu, A Liu - Medicine, 2021 - journals.lww.com
The role of thoracic stereotactic body radiation therapy (SBRT) in addition to epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR-mutant …
growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR-mutant …
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO
R Mazzola, BA Jereczek-Fossa, P Antognoni… - Medical Oncology, 2021 - Springer
In the last years, several evidences demonstrated the role of stereotactic body radiotherapy
(SBRT) in the oligometastatic disease and the possibility to increase survival in selected …
(SBRT) in the oligometastatic disease and the possibility to increase survival in selected …
Group phenotypic composition in cancer
Although individual cancer cells are generally considered the Darwinian units of selection in
malignant populations, they frequently act as members of groups where fitness of the group …
malignant populations, they frequently act as members of groups where fitness of the group …
[HTML][HTML] Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?
V Verma, JY Chang - Translational Lung Cancer Research, 2021 - ncbi.nlm.nih.gov
© Translational Lung Cancer Research. All rights reserved. Transl Lung Cancer Res 2021;
10 (1): 5-8| http://dx. doi. org/10.21037/tlcr-2020-19 failure in these patients are dominated …
10 (1): 5-8| http://dx. doi. org/10.21037/tlcr-2020-19 failure in these patients are dominated …
Immunotherapy and Radiosurgery for Brain and Spine Metastases
Brain metastases (BrM) are a significant cause of morbidity and mortality, occurring in
approximately 10% to 30% of cancer patients at one point in the course of their disease. In …
approximately 10% to 30% of cancer patients at one point in the course of their disease. In …
[引用][C] Oligometastatic disease in context of the radiation oncology alternative payment model: Implications for local consolidative therapy
MS Ning, D Boyce-Fappiano, NG Thaker - JCO Oncology Practice, 2021 - ascopubs.org
Local consolidative therapy (LCT) has emerged as a novel paradigm for the oligometastatic
patient population, 1 which is estimated to grow by nearly 2% each year. 2 Associated …
patient population, 1 which is estimated to grow by nearly 2% each year. 2 Associated …